Aldeyra Therapeutics, Reproxalap, Dry Eye Disease, DED, FDA, Formal Dispute Resolution Request, FDRR, Complete Response Letter, CRL, Office of New Drugs, OND, Ophthalmology

CONCORD, Mass. — September 29, 2026 Aldeyra Therapeutics announced plans to submit a Formal Dispute Resolution Request (FDRR) to...